sofosbuvir 200 MG / velpatasvir 50 MG [Epclusa]
RxNorm concept 2288815, branded drug component (sbdc).
- RxCUI
- 2288815
- Term type
- Branded drug component (SBDC)
- Status
- Active
curl https://api.healthcare.dev/v1/drugs/rxnorm/2288815 \ -H "Authorization: Bearer $HDEV_API_KEY"
Concept
Ingredients and related concepts
Ingredients
Related concepts
- sofosbuvir 200 MG / velpatasvir 50 MG Oral Tablet [Epclusa] (SBD, constitutes)
- sofosbuvir 200 MG / velpatasvir 50 MG Oral Pellet [Epclusa] (SBD, constitutes)
- Epclusa (BN, has ingredient)
- sofosbuvir 200 MG (SCDC, tradename of)
- velpatasvir 50 MG (SCDC, tradename of)
Linked data
NDCs
RxNorm links no NDCs to this concept.
Use it
Look up 2288815 from code or an agent
curl https://api.healthcare.dev/v1/drugs/rxnorm/2288815 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up RxNorm concept 2288815. Tell me its name and term type, its ingredients and related concepts, and the NDCs linked to it.
Source: U.S. National Library of Medicine, release 2026-10-05. No license required (Current Prescribable Content). Reference data, not medical advice.